LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 14.58 | 84.90 | 6 | 663 | 0.0090 | -0.5907 | MN20160318_Q02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 14.58 | 84.90 | 897 | 663 | 1.3521 | 1.2141 | MN20160318_Q02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 16.29 | 84.90 | 19 | 766 | 0.0248 | -0.3759 | MN20160318_Q02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 16.29 | 84.90 | 938 | 766 | 1.2232 | 1.1310 | MN20160318_Q02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 16.29 | 84.90 | 5 | 766 | 0.0065 | -0.5901 | MN20160318_Q02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 16.29 | 84.90 | 920 | 766 | 1.1997 | 1.1180 | MN20160318_Q02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 17.99 | 84.90 | 20 | 898 | 0.0222 | -0.3460 | MN20160318_Q02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 17.99 | 84.90 | 929 | 898 | 1.0334 | 1.0194 | MN20160318_Q02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 17.99 | 84.90 | 7 | 898 | 0.0078 | -0.5195 | MN20160318_Q02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 17.99 | 84.90 | 930 | 898 | 1.0345 | 1.0200 | MN20160318_Q02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 19.69 | 84.90 | 29 | 1239 | 0.0234 | -0.2425 | MN20160318_Q02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 19.69 | 84.90 | 941 | 1239 | 0.7592 | 0.8625 | MN20160318_Q02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 19.69 | 84.90 | 11 | 1239 | 0.0089 | -0.4104 | MN20160318_Q02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 19.69 | 84.90 | 927 | 1239 | 0.7479 | 0.8553 | MN20160318_Q02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 21.40 | 84.90 | 27 | 1454 | 0.0186 | -0.2438 | MN20160318_Q02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 21.40 | 84.90 | 961 | 1454 | 0.6606 | 0.8076 | MN20160318_Q02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 21.40 | 84.90 | 15 | 1454 | 0.0103 | -0.3449 | MN20160318_Q02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 21.40 | 84.90 | 938 | 1454 | 0.6448 | 0.7970 | MN20160318_Q02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 23.10 | 84.90 | 29 | 1616 | 0.0179 | -0.2233 | MN20160318_Q02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 23.10 | 84.90 | 966 | 1616 | 0.5977 | 0.7719 | MN20160318_Q02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 23.10 | 84.90 | 22 | 1616 | 0.0136 | -0.2722 | MN20160318_Q02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 23.10 | 84.90 | 948 | 1616 | 0.5866 | 0.7641 | MN20160318_Q02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 24.81 | 84.90 | 40 | 1769 | 0.0226 | -0.1578 | MN20160318_Q02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 24.81 | 84.90 | 976 | 1769 | 0.5516 | 0.7460 | MN20160318_Q02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 24.81 | 84.90 | 23 | 1769 | 0.0130 | -0.2577 | MN20160318_Q02 | E18 |